Bausch + Lomb Expected to Price IPO at Low End or Below Targeted Range

0 0

The eye-care company, a spinoff of Bausch Health, is set to test the beleaguered new-issue market on Friday.

 25 total views,  2 views today

Leave A Reply

Your email address will not be published.